Wilko Vinyl Dog Flea And Tick Collar, 15% W/W
Revised: 30 September 2008
AN: 00222/2008
Summary of Product Characteristics
Name of the Veterinary Medicinal Product
Wilko Vinyl Dog Flea and Tick Collar, 15% w/w.
Qualitative and quantitative composition
Active substance % w/w mg/collar
Dimpylate (as dimpylatestabilised) 15.0 3,600
Excipients % w/w mg/collar
Brown collar: Ferric oxide red (E172) 0.08 19.2
Charcoal, vegetable (E153) 0.02 4.8
Blue collar: Coomassie Brilliant Blue G 0.012 2.8
Copper Phthalocyanine 0.012 2.8
OB (CAS No. 67210-66-6) 0.005 1.2
Red collar: Rhodamine 6G 0.013 3.2
Basic Violet 11 0.005 1.2
Yellow collar: Solvent Yellow 135 0.013 3.2
Green collar: Solvent Yellow 135 0.013 3.2
Copper Phthalocyanine Green 0.010 2.4
Orange collar: Disperse Yellow 11 0.010 2.4
Rhodamine 6G 0.015 3.6
Rhodamine B 0.005 1.2
For full list of excipients, see section 6.1
Pharmaceutical form
Collar
Coloured flea collar fitted with safety buckle
Clinical Particulars
4.1 Target species
Dogs
Indications for use, specifying the target species
Treatment of dogs infested with fleas (Ctenocephalides felis and C. canis) and ticks (Ixodes ricinus).
Contra-indications
No other insecticide should be used with the collar or within 7 days of removal.
Do not allow the collar to come into contact with nursing females.
Do not use the collar on dogs younger than 12 weeks.
4.4 Special warnings for each target species
Remove collar if any sign of skin irritation occurs.
Check the collar is not too tight, to ensure against irritation.
Do not allow animals to chew the collar.
Remove collar from dog immediately should any signs of drowsiness, listlessness or respiratory difficulties develop soon after fixing the collar.
Special precautions for use
Special precautions for use in animals
For external use only.
Remove fleas from young puppies and nursing females by careful use of a flea comb.
Special precautions to be taken by the person administering the medicinal product to animals
Do not remove collar from pack until ready to use.
Do not allow children to play with the collar.
Do not allow children to suck or chew the collar.
Do not smoke, eat or drink while handling collar.
Do not sleep with pets wearing collars.
Dimpylate / Diazinon is an organophosphorus compound: DO NOT handle if under medical advice not to work with ANTICHOLINESTERASES.
Avoid excessive handling of the collar.
Cut off any excess collar with scissors and dispose of safely.
If you feel unwell after handling the collar, seek medical advice. Wash hands thoroughly after handling the collar.
Other precautions
To help prevent reinfestation, animals’ bedding and regular resting areas, including carpets and soft furnishings, should be treated with a suitable insecticide and vacuumed regularly.
After fitting the collar, do not allow dogs to swim in ponds or other small bodies of water. This will not adversely affect the activity of the collar but is potentially
dangerous to aquatic life.
Adverse reactions (frequency and seriousness)
Typical adverse reactions to organophosphorus compounds are rare.
4.7 Use during pregnancy, lactation or lay
Do not allow contact with nursing females.
Interaction with other medicinal products and other forms of interaction
Do not combine with other organophosphorus compounds or medicines which are not compatible with organophosphorus compounds.
Amounts to be administered and administration route
One collar per animal to be fastened around the neck. Fasten the collar around the dog’s neck, ensuring a comfortable fit; two fingers should fit easily under the collar. Loosen the collar as the dog grows bigger. Cut off excess collar extending beyond buckle and dispose of with the household refuse. Replace collar after 4 months if flea and tick re-infestation is a risk.
Overdose (symptoms, emergency procedures, antidotes) if necessary
Symptoms: Tearing, salivation, muscle twitches, vomiting, loss of reflexes, coma, cyanosis.
Emergency procedure: Remove collar.
Antidote: Atropine.
Withdrawal period(s)
Not applicable
Pharmacological properties
Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides
ATC Vet Code: QP53AF03
5.1 Pharmacodynamic properties
The collar is applied around the dog’s neck. The collar constantly releases dimpylateover a four month period. Fleas and ticks on the skin of the animal come into contact with the dimpylateand are killed.
5.2 Pharmacokinetic particulars
Dimpylateis an organophosphorus compound with a non-systemic action.
Pharmaceutical particulars
List of excipients
Brown collar: Charcoal Vegetable (E153)
Ferric Oxide Red (E172)
Blue collar: Coomassie Brilliant Blue G
Copper Phthalocyanine
OB (CAS No. 67210-66-6)
Red collar: Rhodamine 6G
Basic Violet 11
Yellow collar: Solvent Yellow 135
Green collar: Solvent Yellow 135
Copper Phthalocyanine Green
Orange collar: Disperse Yellow 11
Rhodamine 6G
Rhodamine B
Polyvinyl chloride
Dibutyl Phthalate
Epoxidised Soya Bean Oil
Calcium Stearate
Incompatibilities
Morphine, theophylline, aminophylline, large amounts of intravenous fluids, phenothiazine drugs, pyrantelpalmoate.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years
Special precautions for storage
Protect from direct sunlight.
Do not store above 25°C.
Do not remove the collar from the pack until you are ready to fit it.
Nature and composition of immediate packaging
Clear, colourless high-density polyethylene blister, containing one PVC collar, heat sealed on varnished fibreboard/aluminium foil/fibreboard laminate backing card.
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
EXTREMELY DANGEROUS to fish and aquatic life.
Do not contaminate ponds, waterways or ditches with the collar or empty packaging.
Marketing authorisation holder
Beaphar Ltd.
Homefield Road
Haverhill
Suffolk
CB9 8QP
Marketing authorisation number
Vm 05496/4027
Date of first authorisation
Date: 13 September 2001
Date of revision of the text
Date:November 2013
Approved:01/11/2013